November 2008

Dear Society members,
I hope you all had a great summer and are enjoying some beautiful Fall weather (actually it is lightly snowing in Chicago today). Before you know it, it will be time for the USCAP meeting in Boston.

Just a note about dues - this year for the first time you may pay your Society dues online. You will be receiving an e-mail about this soon.

SH Symposium at the USCAP Meeting in Boston, March 8, 2009
The symposium this year, entitled "Tumours of the Haematopoietic and Lymphoid Tissues: Introducing the Revised WHO" has been organized by Steve Swerdlow and Jim Vardiman. This is obviously a very timely topic. They have compiled an outstanding group of speakers and the program is as follows:

D. A. Arber - An algorithmic approach to the classification of acute leukemias
A. Orazi - Myelodysplastic syndromes and related disorders, diagnosis and classification
S. A. Pileri - Dealing with the histiocytic neoplasms
S. H. Swerdlow - What to know about the B-cell neoplasms
E. S. Jaffe - T and NK cell neoplasms, an update
N. L. Harris - Applying the new WHO in your diagnostic practice

Pathologist-in-Training Award at the next USCAP Meeting in Boston
The Society for Hematopathology Pathologist-in Training Award is given each year to a fellow, resident or medical student who presents an outstanding paper (poster or platform) related to hematopathology at the annual USCAP meeting. Previous winners are not eligible for this award. Papers are judged by a committee comprised of members of the SH Executive Committee and scored for scientific approach, significance and presentation. To be eligible for the award, all nominees with posters must be at their posters during the official poster sessions so that they can discuss their work with the judges. Each winner receives a $500 prize. Trainees with posters accepted for the Stowell-Orbison competition in the Hematopathology category are automatically nominated and do not need to submit an application. To nominate other trainees, please visit the website ( to check the eligibility requirements and complete the nomination form. The application form should be FAXed to the SH office at 706-733-8033 no later than February 5, 2008.

Education Committee and Director's Breakfast Meeting at the next USCAP Meeting in Boston, Sunday, March 8, 2008
The Education Committee, chaired by Kaari Reichard, has planned an outstanding program for this upcoming USCAP Fellowship Director's meeting (shown below). Presentations by each speaker will be followed by time for question and answers. I know program directors will want to attend and participate in the discussion about these challenging issues.

7:30-8am:"Update on standardization of fellowship recruitment timelines" by Dr. James Crawford, Chair of Pathology, University of Florida
8-8:30am:"ACGME competencies, ways to assess them and program requirements" by Dr. Mark Brissette, Denver VA Medical Center

Meeting of the European Association for Haematopathology (EAHP), Bordeaux, September, 2008
The EAHP meeting held in Bordeaux, France was a huge success. There were 716 attendees with 20% of these participants from North America. The meeting featured the Bone Marrow Symposium and Workshop, the Lymphoma Symposium and Workshop as well as an Educational Session. The beautiful historic city of Bordeaux complemented the outstanding scientific sessions. Thanks to Antoine de Mascarel and the local organizing committee and to all of the EAHP and SH members who were responsible for putting on an outstanding meeting. The next EAHP symposium and workshop will be held in Uppsala, Sweden, September 2010.

SH/EAHP Workshop, Cleveland, Ohio, September 24-26, 2009
The next Society for Hematopathology workshop is being organized by Eric Hsi and James Cook. The theme is the spectrum of immunoproliferative disorders and the border between plasma cell neoplasms and B-cell lymphomas. Cases submitted will emphasize differential diagnostic difficulties between small B-cell lymphomas/leukemias with plasmacytic maturation and plasma cell myeloma, the spectrum of plasmablastic lymphomas, and the clinical, phenotypic, and molecular genetic features of these diagnostic entities. Both lymph node and bone marrow biopsies will be welcome. Cases will be accepted Dec 15th 2008 - Feb 16th 2009. Details for case submission, preliminary program, venue description, and registration information can be found at

As a unique component of this meeting, the organizers are soliciting cases of lymphoplasmacytic lymphoma (LPL) (nodal preferred) or marginal zone lymphomas (nodal or splenic) for gene expression profiling studies (to be performed for the workshop by Dr. John Chan, Univ. of Nebraska). If successful, preliminary data from these studies will be presented at the Workshop. Contributors will be included as authors in any resulting manuscript to be generated on behalf of the SH. Specimen requirements: Frozen tissue from untreated lymph node-based LPL or marginal zone lymphomas. Frozen cells from bone marrow or blood may be acceptable if the neoplastic cells are the majority of cells in the specimen. Paraffin embedded material is not acceptable. Cases should be well documented, with flow cytometry and/or immunohistochemical phenotyping. Information regarding serum/urine protein electrophoresis studies should also be provided if possible. A detailed cutting protocol and directions for shipping are available on the meeting website.

Contact information:
Eric D. Hsi, MD:
James R. Cook MD, PhD:

SH/ASCP Companion Meetings
The SH/ASCP companion meeting in September in Baltimore, moderated by Pat Aoun and Jim Cook, was a great success with about 75 pathologists attending. The meeting featured updates in hematopathology with a lecture by Robert Hasserjian on classification of myeloid disorders in the revised WHO classification, a presentation by Lisa Rimsza on classification of diffuse large B-cell lymphoma, and a lecture by Pat Aoun on acute lymphoblastic leukemia/lymphoma. Pat Aoun has just completed her term on the ASCP Companion Meeting Committee. Thanks to Pat for her excellent leadership and work on this committee. The committee, now chaired by Jim Cook, is already planning the 2009 ASCP companion meeting in Chicago. The topics and speakers for that meeting include large granular lymphocyte disorders (Bill Morice), plasma cell myeloma (Pei Lin), and marginal zone lymphomas (Jim Cook). The details of that program will be available at the upcoming USCAP meeting.

Thanks to all of you who are actively involved in this Society and contribute to it in so many ways. If you are interested in serving on a committee for this Society, please contact me by email:

I look forward to seeing you in Boston.

LoAnn Peterson